States Sue Trump Title X Grant Conditions: 23 AGs Challenge HHS Rules

• A coalition of 23 states has sued the Trump administration over new ideological conditions for federal Title X family planning grants.
• The Department of Health and Health Services' FY 2027 Notice of Funding Opportunity disproportionately judges applicants based on opposition to hormonal contraception "overmedicalization," DEI policies, and transgender identities.
• States argue these conditions, imposed "arbitrarily and capriciously" under the Administrative Procedure Act, jeopardize essential reproductive and sexual healthcare services.
• The lawsuit, led by New York Attorney General Letitia James, seeks to strike down these conditions, preventing them from being used against grant applicants or for rescinding funds.
• Officials warn that the new requirements could lead to financial shortfalls for states, clinic closures, and reduced access to care for low-income residents.

The outcome of this lawsuit concerning the States sue Trump Title X grant conditions will therefore have profound implications for the future of federal funding for reproductive healthcare nationwide.

A coalition of 23 states has initiated legal action against the Trump administration, challenging new federal priorities for the nation's sole federal grant program dedicated to family planning, Title X. The lawsuit, filed in Maryland federal court, targets the Department of Health and Human Services' (HHS) Notice of Funding Opportunity (NOFO) for Title X grants in the 2027 fiscal year, which was released in July. These new conditions are described by the states as a "conservative overhaul" of the program, imposing ideological requirements on grant recipients.

The core of the states' complaint revolves around specific criteria outlined in the HHS NOFO. Applicants for Title X funding will now be disproportionately evaluated based on their adherence to departmental priorities that include opposition to the "overmedicalization" of hormonal contraception, rejection of diversity, equity, and inclusion (DEI) policies, and a refusal to acknowledge transgender identities and their specific medical needs. Furthermore, the notice explicitly states that any recipient ceasing compliance with these new priorities could face the complete loss of their grant funding.

New York Attorney General Letitia James is leading this significant legal challenge, joined by the attorneys general of Maryland, Massachusetts, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Michigan, Minnesota, Nevada, New Jersey, New Mexico, Oregon, Rhode Island, Vermont, Virginia, Washington, and Wisconsin, alongside the governors of Kentucky and Pennsylvania.

The litigant states contend that the conditions outlined in the HHS notice were imposed "arbitrarily and capriciously," a violation of the Administrative Procedure Act (APA). Their lawsuit seeks a judicial declaration that these challenged conditions be removed from the notice, ensuring that non-compliance with the department's new priorities cannot be used to penalize grant applicants or justify the rescission of awarded funds. This legal maneuver aims to preserve the integrity and accessibility of Title X funding, which supports a broad range of reproductive and sexual healthcare services.

This current legal battle is not an isolated incident but rather echoes previous disputes over Title X funding during the Trump administration. During his first term, President Trump oversaw a significant revision to Title X grant conditions in 2019. That policy banned the use of federal funds for performing, promoting, or supporting abortion as a method of family planning, going so far as to prohibit even the mention of abortion care to patients by grant recipients, under penalty of losing funds. That earlier policy also prompted a lawsuit from 21 states, highlighting a recurring pattern of federal attempts to reshape the program's scope through ideological conditions. HHS has declined to comment on the ongoing litigation.

State officials argue that these new Title X grant conditions will have severe repercussions for public health and state budgets. Illinois Attorney General Kwame Raoul emphasized that supporting family planning programs is crucial for empowering individuals, particularly women, to make informed decisions about their health and improve their social and economic prospects. He stated that the administration's decision to politicize the Title X program jeopardizes essential healthcare services and risks serious public health consequences. California Attorney General Rob Bonta further asserted that Title X is designed to ensure accessible family planning and reproductive care for all, and that conditioning millions in federal funding on ideological terms makes care harder, rather than healthier.

The states' complaint highlights the potential for significant financial shortfalls, as state governments would be left to cover the costs of critical health services if federal funding is withdrawn due to these new conditions. Many states, officials noted, would be unable to maintain current funding levels using only state dollars. This anticipated outcome could lead to a curtailment of services and even the closure of clinics, ultimately depriving many low-income residents of crucial family planning and reproductive health services. The outcome of this lawsuit concerning the States sue Trump Title X grant conditions will therefore have profound implications for the future of federal funding for reproductive healthcare nationwide.

Lawyers advising healthcare providers, non-profits, or state agencies receiving federal funding, particularly Title X, should closely monitor this litigation. Its outcome will determine the legality of federal agencies imposing ideological conditions on grant eligibility, potentially impacting future compliance requirements, funding availability, and the scope for challenging federal grant terms.

Source: Original reporting via Associated Press